EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Interactions Between Circulating Tumor Cells and the Immune System in Colorectal Cancer: Friends or Foes?

Michela De Meo iD, Chiara Nicolazzo iD

Cancers · 29.06.2026 · 18 (13) · 2104

DOI: 10.3390/cancers18132104 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 29.06.2026. Verfasst von Michela De Meo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Liquid Biopsy Unit, Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 187 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is a leading cause of cancer death worldwide, mainly due to metastasis. Circulating tumor cells (CTCs) act as the biological “seeds” of dissemination, traveling through the bloodstream to colonize distant organs. However, the blood is a hostile environment where CTCs must constantly face immune pressure. This review explores the bidirectional interactions between CTCs and immune cells in CRC, asking whether CTCs are merely vulnerable targets of immunosurveillance or can exploit the immune system for survival and metastasis. We dissect intrinsic and extrinsic immune evasion mechanisms, including MHC-I modulation, immune checkpoint expression (PD-L1, CD47, FasL), platelet cloaking, and neutrophil extracellular traps (NETs). Furthermore, we examine how CTCs form heterotypic clusters with monocytes, neutrophils, and lymphocytes, creating pro-metastatic niches and promoting phenotypic plasticity. The impact of CTCs on systemic immunity, including reprogramming of NK cells, T lymphocytes, and myeloid-derived suppressor cells (MDSCs), is discussed. Importantly, we highlight the emerging role of CTCs as dynamic biomarkers for immunotherapy, focusing on the predictive value of PD-L1+ CTCs and the potential of CTC-derived neoantigens for personalized vaccination. Despite progress, challenges remain in standardization, detection sensitivity, and clinical validation. Understanding the equilibrium between immune elimination and evasion by CTCs is crucial to develop novel interventions that interrupt the metastatic dialog and improve outcomes for CRC patients.

Schlagwörter

Stichwörter der Autor:innen

PD-L1circulating tumor cellscolorectal cancerimmune checkpointimmune evasionimmunotherapyliquid biopsymetastasisneutrophil extracellular trapstumor microenvironment

Autor:innen und Institutionen

  • Cancer Liquid Biopsy Unit, Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.
  • Department of Life Science, Health, and Health Professions, Link Campus University, 00165 Rome, Italy.

ORCID-Profile: Michela De Meo, Chiara Nicolazzo

Zitieren

APA

De Meo, M., & Nicolazzo, C. (2026). Interactions Between Circulating Tumor Cells and the Immune System in Colorectal Cancer: Friends or Foes?. Cancers, 18(13), 2104. https://doi.org/10.3390/cancers18132104

Vancouver

De Meo M, Nicolazzo C. Interactions Between Circulating Tumor Cells and the Immune System in Colorectal Cancer: Friends or Foes?. Cancers. 2026;18(13):2104. doi:10.3390/cancers18132104

BibTeX
@article{DeMeo2026,
  author = {De Meo, Michela and Nicolazzo, Chiara},
  title = {Interactions Between Circulating Tumor Cells and the Immune System in Colorectal Cancer: Friends or Foes?},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {13},
  pages = {2104},
  doi = {10.3390/cancers18132104}
}
Kostenlos starten →